We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Formulating Cannabinoid Particles for Therapeutics

Formulating Cannabinoid Particles for Therapeutics content piece image

Recent literature increasingly supports the therapeutic use of cannabinoids in the development of novel medicines. Nanoparticles play a crucial role in increasing the solubility, stability, benefits and safety of cannabinoids as therapeutic agents. In this webinar, we review the challenges of cannabinoid-based drug development, and present the opportunities of nanotechnology in formulating cannabinoid nanoparticles.

During this webinar we will discuss:

  • Clinical Snapshot: History and challenges of cannabinoid-based drug development.
  • Technology Overview: Opportunities in nanotechnology and the microfluidic approach.
  • Characterization Methods: ELISA for dissolution studies.
  • Sample Preparation Challenges: Polymer nanoparticles, liposomes, emulsions on the HPLC.
  • Research Findings: The impact of lipid composition on liposome stability and cannabinoid drug encapsulation efficiency
A picture of Dr Natalia Sannikova
Dr Natalia Sannikova
Research & Development Manager, Ascension Sciences
A picture of Tomas Skrinskas
Tomas Skrinskas
Founder & CEO, Ascension Sciences